Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides: The First Double-Blind, Randomized, Controlled Trial in Pre-term Infants

There is growing evidence supporting the benefit of human milk oligosaccharides (HMOs) on reducing risk of illnesses and improving immune function in newborn infants, but evidence in pre-term infants is lacking. This randomized, double-blind, placebo-controlled trial (NCT03607942) of pre-term infant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hascoët, Jean-Michel, Chevallier, Marie, Gire, Catherine, Brat, Roselyne, Rozé, Jean-Christophe, Norbert, Karine, Chen, Yipu, Hartweg, Mickaël, Billeaud, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119431/
https://www.ncbi.nlm.nih.gov/pubmed/35601412
http://dx.doi.org/10.3389/fped.2022.858380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119431/
https://www.ncbi.nlm.nih.gov/pubmed/35601412
http://dx.doi.org/10.3389/fped.2022.858380

Ejemplares similares